Wedbush Increases Healthpeak Properties (NYSE:DOC) Price Target to $25.00

Healthpeak Properties (NYSE:DOC) had its price target increased by stock analysts at Wedbush from $22.00 to $25.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Wedbush’s price objective points to a potential upside of 14.47% from the stock’s previous close.

Several other equities research analysts also recently commented on DOC. Mizuho restated a “buy” rating and issued a $22.00 target price on shares of Healthpeak Properties in a research note on Monday, April 22nd. Argus upgraded shares of Healthpeak Properties to a “strong-buy” rating in a research note on Thursday, May 9th. Royal Bank of Canada boosted their target price on shares of Healthpeak Properties from $21.00 to $22.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. StockNews.com upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Tuesday, July 23rd. Finally, Scotiabank boosted their target price on shares of Healthpeak Properties from $22.00 to $23.00 and gave the company a “sector outperform” rating in a research note on Thursday, May 16th. Six research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $20.64.

Healthpeak Properties Trading Down 0.0 %

NYSE:DOC opened at $21.84 on Monday. Healthpeak Properties has a 12 month low of $15.24 and a 12 month high of $22.13. The firm has a market cap of $15.37 billion, a price-to-earnings ratio of 62.40, a P/E/G ratio of 2.73 and a beta of 1.11. The company has a quick ratio of 0.69, a current ratio of 0.70 and a debt-to-equity ratio of 0.91. The company’s 50 day moving average is $19.89 and its 200-day moving average is $17.37.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The firm had revenue of $695.50 million during the quarter, compared to the consensus estimate of $665.11 million. During the same period in the prior year, the business earned $0.45 EPS. The company’s revenue for the quarter was up 27.5% compared to the same quarter last year. Equities analysts anticipate that Healthpeak Properties will post 1.79 EPS for the current year.

Institutional Trading of Healthpeak Properties

Several large investors have recently bought and sold shares of DOC. Parallel Advisors LLC boosted its stake in shares of Healthpeak Properties by 274.6% during the fourth quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 2,985 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Healthpeak Properties by 645.4% during the fourth quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock valued at $128,000 after purchasing an additional 8,352 shares in the last quarter. Stratos Wealth Partners LTD. acquired a new stake in shares of Healthpeak Properties during the fourth quarter valued at about $134,000. Koshinski Asset Management Inc. acquired a new stake in shares of Healthpeak Properties during the fourth quarter valued at about $146,000. Finally, Sapient Capital LLC acquired a new stake in shares of Healthpeak Properties during the fourth quarter valued at about $152,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.